Dapagliflozin: an effective adjunctive treatment in type 1 diabetes

Category Primary study
JournalCardiovascular Endocrinology and Metabolism
Year 2021
This article has no abstract
Epistemonikos ID: 0c239eeb27dc879ec24323669ed855662fde048e
First added on: Jul 02, 2024